相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Constructing a representative in-silico population for paediatric simulations: Application to HIV-positive African children
Roeland E. Wasmann et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Tuberculosis Preventive Therapy for Individuals Exposed to Drug-resistant Tuberculosis: Feasibility and Safety of a Community-based Delivery of Fluoroquinolone-containing Preventive Regimen
Amyn A. Malik et al.
CLINICAL INFECTIOUS DISEASES (2020)
Pharmacokinetics, Safety, and Dosing of Novel Pediatric Levofloxacin Dispersible Tablets in Children with Multidrug-Resistant Tuberculosis Exposure
Anthony J. Garcia-Prats et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis
Charles A. Peloquin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Clinical and Cardiac Safety of Longterm Levofloxacin in Children Treated for Multidrug-resistant Tuberculosis
Anthony J. Garcia-Prats et al.
CLINICAL INFECTIOUS DISEASES (2018)
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)
James A. Seddon et al.
TRIALS (2018)
Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis
Paolo Denti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Global burden of drug-resistant tuberculosis in children: a mathematical modelling study
Peter J. Dodd et al.
LANCET INFECTIOUS DISEASES (2016)
Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands
Sundari R. Mase et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
Prediction of Fat-Free Mass in Children
Hesham Saleh Al-Sallami et al.
CLINICAL PHARMACOKINETICS (2015)
Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates
Helen E. Jenkins et al.
LANCET (2014)
Preventive Therapy for Child Contacts of Multidrug-Resistant Tuberculosis: A Prospective Cohort Study
James A. Seddon et al.
CLINICAL INFECTIOUS DISEASES (2013)
A Pharmacokinetic Standard for Babies and Adults
Nick Holford et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose
R. J. Keizer et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Paediatric use of second-line anti-tuberculosis agents: A review
James A. Seddon et al.
TUBERCULOSIS (2012)
Randomized Pharmacokinetic and Pharmacodynamic Comparison of Fluoroquinolones for Tuberculous Meningitis
Guy E. Thwaites et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
Brian J. Anderson et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Mechanism-based concepts of size and maturity in pharmacokinetics
B. J. Anderson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis
Charles A. Peloquin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies
Radojka M. Savic et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2007)
Glomerular filtration rate via plasma iohexol disappearance: Pilot study for chronic kidney disease in children
G. J. Schwartz et al.
KIDNEY INTERNATIONAL (2006)
Ways to fit a PK model with some data below the quantification limit
SL Beal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
分享论文
